0
Medicilon congratulates MindRank's GLP-1RA small molecule oral drug for successfully administering the first subject in clinical www.medicilon.comban site
MindRank's GLP-1RA small molecule oral drug has been successfully administered to the first subject in clinical phase I. Medicilon as a strategic partner of MindRank, provided MDR-001 with API process development and preparation R&D services to help speed up its research and development.
Comments (0)
You need to be logged in to write comments!
This story has no comments.